Shareholders' equity · 2019–2025

Monte Rosa Therapeutics shareholders' equity

$233M+4.5% · FY2025

Monte Rosa Therapeutics (GLUE) reported $233M in shareholders' equity for fiscal 2025, +4.5% year on year.

−$12.1M2019−$48.7M2020$348M2021$271M2022$179M2023$223M2024$233M2025
Monte Rosa Therapeutics — Shareholders' equity, 2019–2025
Fiscal yearShareholders' equityChangeFiling
FY20252025-12-31$233M+4.5%Open →
FY20242024-12-31$223M+24.4%Open →
FY20232023-12-31$179M−34.0%Open →
FY20222022-12-31$271M−21.9%Open →
FY20212021-12-31$348M+$396MOpen →
FY20202020-12-31−$48.7M−$36.6MOpen →
FY20192019-12-31−$12.1M—Open →

Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Shareholders' equity at companies of similar size

Full ranking by shareholders' equity →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Monte Rosa Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/monte-rosa-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Monte Rosa Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/monte-rosa-therapeutics/shareholders-equity

BibTeX

@misc{companiesranked-en-company-monte-rosa-therapeutics-shareholders-equity-2026,
  author       = {{CompaniesRanked}},
  title        = {{Monte Rosa Therapeutics shareholders' equity}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/monte-rosa-therapeutics/shareholders-equity}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001193125-26-336711 · August 6, 2026

{{cite web |title=Monte Rosa Therapeutics shareholders' equity — 10-Q (0001193125-26-336711) |url=https://www.sec.gov/Archives/edgar/data/1826457/000119312526336711/glue-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Monte Rosa Therapeutics overview